Hyperandrogenism during menopause is often underestimated by clinicians and attributed to the natural aging process. Hyperandrogenism can be associated with some metabolic abnormalities linked together in a vicious circle by insulin resistance. We present the case of an elderly woman affected with type 2 diabetes and obesity who reported the occurrence of clinical hirsutism after physiological menopause at the age of 47 years. At presentation, physical examination and Ferriman-Gallwey score revealed a condition of moderate hirsutism, with markedly increased levels of plasma testosterone and delta-4-androstenedione, obesity (body mass index 31.9), and inadequate glycemic control (glycated hemoglobin 65 mmol/mol). The patient underwent a thorough differential diagnosis by a multidisciplinary team approach, including the various causes of hyperandrogenism during menopause. After choosing surgical option as the appropriate treatment, clinical resolution of hirsutism was observed alongside patient satisfaction and marked improvement of the glucometabolic profile.

De Taddeo, S., Andreadi, A., Minasi, A., D'Ippolito, I., Borelli, B., Meloni, M., et al. (2023). Surgical treatment of post-menopausal ovarian hyperandrogenism improves glucometabolic profile alongside clinical hirsutism. SAGE OPEN MEDICAL CASE REPORTS, 11, 1-4 [10.1177/2050313X231178404].

Surgical treatment of post-menopausal ovarian hyperandrogenism improves glucometabolic profile alongside clinical hirsutism

De Taddeo, Sofia;Andreadi, Aikaterini;Minasi, Alessandro;D'Ippolito, Ilenia;Borelli, Barbara;Meloni, Marco;Romano, Maria;Cacciotti, Laura;Rizzo, Giuseppe;Patrizi, Lodovico;Bellia, Alfonso;Lauro, Davide
2023-01-01

Abstract

Hyperandrogenism during menopause is often underestimated by clinicians and attributed to the natural aging process. Hyperandrogenism can be associated with some metabolic abnormalities linked together in a vicious circle by insulin resistance. We present the case of an elderly woman affected with type 2 diabetes and obesity who reported the occurrence of clinical hirsutism after physiological menopause at the age of 47 years. At presentation, physical examination and Ferriman-Gallwey score revealed a condition of moderate hirsutism, with markedly increased levels of plasma testosterone and delta-4-androstenedione, obesity (body mass index 31.9), and inadequate glycemic control (glycated hemoglobin 65 mmol/mol). The patient underwent a thorough differential diagnosis by a multidisciplinary team approach, including the various causes of hyperandrogenism during menopause. After choosing surgical option as the appropriate treatment, clinical resolution of hirsutism was observed alongside patient satisfaction and marked improvement of the glucometabolic profile.
2023
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/13
Settore MED/40
English
Con Impact Factor ISI
Hirsutism
post-menopause ovarian hyperandrogenism
surgical treatment
De Taddeo, S., Andreadi, A., Minasi, A., D'Ippolito, I., Borelli, B., Meloni, M., et al. (2023). Surgical treatment of post-menopausal ovarian hyperandrogenism improves glucometabolic profile alongside clinical hirsutism. SAGE OPEN MEDICAL CASE REPORTS, 11, 1-4 [10.1177/2050313X231178404].
De Taddeo, S; Andreadi, A; Minasi, A; D'Ippolito, I; Borelli, B; Meloni, M; Romano, M; Ruotolo, V; Cacciotti, L; Rizzo, G; Patrizi, L; Bellia, A; Laur...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
10.1177_2050313X231178404.pdf

accesso aperto

Licenza: Creative commons
Dimensione 407.98 kB
Formato Adobe PDF
407.98 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/336747
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact